相关实验视频
Updated: Jul 13, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.4K
一种古老病毒编码的抗CRISPR蛋白质通过抑制Cas RNP复合体周转率来抑制III-B类型免疫力
Jilin Liu1, Qian Li1, Xiaojie Wang1
1National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, P.R. China.
Nucleic acids research
|October 18, 2023
概括
一种新的古老病毒蛋白,AcrIIIB2,通过向病毒基因,有效抑制III-B型CRISPR-Cas免疫力. 这种抗CRISPR蛋白质破坏Cmr-α核核蛋白复合体,阻断病毒复制.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 病毒学 病毒学
背景情况:
- 克里斯普尔-卡斯系统为 prokaryotes 提供对病毒的适应性免疫力.
- 病毒使用抗CRISPR蛋白来抵消CRISPR-Cas防御.
研究的目的:
- 为了识别和描述一种新型的古老病毒编码的抗CRISPR蛋白,AcrIIIB2.2.
- 为了研究AcrIIIB2抑制III-B型CRISPR-Cas免疫的机制.
主要方法:
- 在体内测试以评估AcrIIIB2对III-B型CRISPR-Cas免疫的抑制.
- 生物化学测试以确定AcrIIIB2与Cmr4α的相互作用及其对Cmr-α核核蛋白复合体 (RNP) 活性的影响.
- 在体外实验分析AcrIIIB2对RNase,ssDNase和Cmr-α RNP.cOA合成活动的AcrIIIB2的影响.
主要成果:
- 在体内,AcrIIIB2抑制了III-B型CRISPR-Cas免疫力,而不管目标病毒基因的表达时间.
- AcrIIIB2与Cmr4α子单元,标RNA和Cmr-α RNP组成一个复合体.
- 在特定的目标RNA-to-RNP比率下,AcrIIIB2在体外抑制Cmr-α RNP的RNase,ssDNase和coA合成活动,可能是通过防止分裂RNA解离.
结论:
- AcrIIIB2是一种新型抗CRISPR蛋白,可以抑制复杂的III-B型CRISPR-Cas系统.
- AcrIIIB2的机制涉及干扰Cmr-α RNP功能,可能是通过阻止目标裂变后的基质访问.
- 这一发现揭示了病毒逃避策略和反CRISPR蛋白质的多方面的作用.
相关概念视频
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
The Antiviral System of Bacteria and Archaea: CRISPR
31
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
31
CRISPR
52.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.0K
Viruses of Archaea
12
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
12
CRISPR/Cas9 Genome Editing
23
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
23
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

